Showing results (1771-1780 of 2,037) with videos related to

Sort By:
Pageof 204
JAMA Cardiology|June 27, 2019
Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking ProgramJavier A Valle, Thomas J Glorioso, Rory Bricker, et al.
Prostate Cancer and Prostatic Diseases|March 16, 2022
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancerLandon C Brown, Susan Halabi, Jason A Somarelli, et al.
JACC. Cardiovascular Interventions|November 12, 2016
Comparative Assessment of Procedure Cost and Outcomes Between Guidewire and Crossing Device Strategies to Cross Peripheral Artery Chronic Total OcclusionsSubhash Banerjee, Haekyung Jeon-Slaughter, Shirling Tsai, et al.
The Journal of Invasive Cardiology|March 16, 2018
Contemporary Use of Laser During Percutaneous Coronary Interventions: Insights from the Laser Veterans Affairs (LAVA) Multicenter RegistryJudit Karacsonyi, Ehrin J Armstrong, Huu Tam D Truong, et al.
Annals of Surgery|August 11, 2015
Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patientsLinwah Yip, Marina N Nikiforova, Jenny Y Yoo, et al.
Journal of the American College of Cardiology|February 11, 2012
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008J Matthew Brennan, David Dai, Manesh R Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Retroviral delivery of peptide modulators of cellular functionsJ B Lorens, M K Bennett, D M Pearsall, et al.
The World Journal of Men'S Health|September 1, 2022
Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific AntigenZoe D Michael, Srinath Kotamarti, Rohith Arcot, et al.
European Urology Oncology|November 18, 2025
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel StudyAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
The Clinical Neuropsychologist|October 24, 2025
Cognitive factor structure of the NACC UDS-3 neuropsychological battery across ethno-racial, linguistic, and cognitive status groupsEmily F Matusz, Jacob Fiala, Andrew M Kiselica, et al.
Pageof 204